Solural Pharma
  • Pharmaceutical Development Services
  • Partnering & investors
  • About
  • Contact
  • News
Select Page

New patent acquisition agreement

by Solural Pharma | Nov 16, 2022 | News

Solural Pharma has entered an agreement with Contera Pharma A/S to transfer all proprietary rights for the SOL 707 Morning Akinesia to Contera Pharma.

Recent news

  • New patent acquisition agreement November 16, 2022
  • New Eurasia patent December 25, 2020
  • New Manufacturing Authorisation December 18, 2020

Career

If you are interested in joining Solural Pharma ApS, we are seeking professionals, technicians and consultants with expertise within drug development. Please contact 
career@soluralpharma.com
 for more information about available positions.

Privacy Policy

  • Contact
  • News
Vedligehold af onlineeftersyn.dk fra 2022